Indaptus Therapeutics INDP
NASDAQ INDP
$2.12 -0.18 (-7.83%)
At close: Oct 1, 2026 · 4:00 PM EDT

Indaptus Therapeutics (INDP) Return on Equity [ROE] (2021 - 2026)

Updated

Indaptus Therapeutics' Return on Equity [ROE] was -234.11% in Q2 2026, up 2667.76 percentage points from -2901.87% a year earlier and up 557.83 percentage points from the prior quarter.

Analysis

Indaptus Therapeutics (INDP) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Equity [ROE] at Indaptus Therapeutics came in at -558.97%, down 367.15 percentage points from FY2024.

  • Return on Equity [ROE] has now declined for four consecutive years, with a four-year change of -515.62 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Equity [ROE] was -191.82% in FY2024 (-102.58 pp), -89.24% in FY2023 (-39.97 pp), -49.27% in FY2022 (-5.92 pp) and -43.35% in FY2021.
  • The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q2 2024.
  • Compared with a year earlier, Return on Equity [ROE] was higher in 1 of the last eight quarters, with an average year-over-year change of -255.33 percentage points.
  • The best year-over-year quarter for Return on Equity [ROE] over five years was Q2 2026 (a gain of 2667.76 percentage points); the worst was Q2 2025 (a drop of 2689.59 percentage points).
  • Per Business Quant data, INDP's Return on Equity [ROE] in the three quarters before Q2 2026 was -791.94% (Q1 2026), -511.35% (Q4 2025) and -1080.99% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Indaptus Therapeutics 147.46 Mn 120.07 Mn - -234.11%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -234.11%
Mar 31, 2026 -791.94%
Dec 31, 2025 -511.35%
Sep 30, 2025 -1,080.99%
Jun 30, 2025 -2,901.87%
Mar 31, 2025 -474.31%
Dec 31, 2024 -308.92%
Sep 30, 2024 -252.66%
Jun 30, 2024 -212.28%
Mar 31, 2024 -148.03%
Dec 31, 2023 -119.51%
Sep 30, 2023 -95.91%
Jun 30, 2023 -78.32%
Mar 31, 2023 -69.69%
Dec 31, 2022 -57.13%
Sep 30, 2022 -48.44%
Jun 30, 2022 -43.47%
Mar 31, 2022 -50.31%
Dec 31, 2021 -49.33%
Sep 30, 2021 -85.96%
API Access

Indaptus Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INDP&period=max&api_key=YOUR_API_KEY